| Today's Open | $48.55 |
|---|---|
| Previous Close | $48.75 |
| Daily Range | $46.48 - $48.89 |
| 52-Week Range | $41.52 - $59.24 |
| Market Cap | $3.5B |
| P/E Ratio | -52.42 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 781,089 |
| Average Daily Volume | 1,155,796 |
| Current FY EPS | -$1.03 |
Sector
Healthcare
Industry
Drugs
Medivation, Inc. (MDVN) Description
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/
News & Commentary
Why Medivation Shares Retreated
Is one company's gain another's pain?J&J to Buy Aragon for $1 Billion - Analyst Blog
J&J to Buy Aragon for $1 Billion - Analyst BlogJ.P. Morgan Reiterates Overweight Rating on Medivation Following Aragon Pharmaceuticals Acquisition
J.P. Morgan Reiterates Overweight Rating on Medivation Following Aragon Pharmaceuticals Acquisition AnnouncementMedivation, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 04:
Medivation, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 04:00 PMMDVN's Top Competitors
(-4.45%)
(-0.08%)
(-1.73%)
(-1.65%)